Advances in Diagnosis and Prevention of COVID-19: Vaccine Effectiveness, Adverse Events, SARS-CoV-2 Variants

Dear Colleagues,

To date, coronavirus disease 2019 (COVID-19) has resulted in global public health challenges. Quick and accurate testing tools for COVID-19 diagnosis have become a prerequisite to comprehending the detailed number of identified cases in the world. The available diagnosis tools have been based on the detection of viral genes, human antibodies, and viral antigens. Preventive measures are an essential strategy to limit the spread of cases. Preventive strategies are focused on careful infection control, including timely diagnosis, treatment, and vaccination. COVID-19 vaccination has been revealed to contribute to reducing hospitalization rates, disease severity, and deaths from infection as an important tool in prevention. In other words, safe and effective vaccines have played a critical role in controlling the current pandemic. Despite remarkable achievements in vaccine development, COVID-19 is not likely to be eradicated. This problem is in part due to new variants that can undercut the effectiveness of current COVID-19 vaccines. Therefore, there is much work to be performed relating to the diagnosis and prevention of COVID-19. This Special Issue aims to identify essential knowledge for researchers who are working on the improvement of the future prevention of COVID-19.

Dr. Soheil Ebrahimpour
Dr. Mostafa Javanian
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.